Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
SUBSCRIBE FOR FREE
Twitter
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine > News > Coffee may protect against prostate cancer
  • News

Coffee may protect against prostate cancer

  • 20 January 2021
  • Janet Fricker
Coffee may protect against prostate cancer
Total
0
Shares
0
0
0
0
0

Drinking several cups of coffee every day may be linked to a lower risk of developing prostate cancer. The meta-analysis study, published in BMJ Open, (11 January) found that each additional daily cup of coffee was associated with a 1% reduction in prostate cancer risk. However, the study should not be considered as giving men a freehand to drink limitless coffee as excessive caffeine consumption can cause negative health effects. A review,  suggests that a moderate consumption of 400mg/day caffeine poses no significant health risks.

Coffee represents one of the most widely consumed beverages in the world, containing many bioactive substances including antioxidants from the beans (including polyphenols and diterpenes) and antioxidants produced during the roasting process. In previous studies, coffee consumption has been linked to a lower relative risk of liver, bowel, and breast cancers. Inconsistent associations, however, have been found for the link between coffee intakes and risk of prostate cancer, with some studies not detecting any such associations and others suggesting lower risks of localised and advanced prostate cancer relating to increased intakes.

Since coffee is such a popular drink, the authors reason, even a small individual health effect might exert substantial overall public health benefits.

For the study, Kefeng Wang, (Shengjing Hospital of China Medical University, Liaoning, China), Wang and colleagues undertook a literature search identifying 16 prospective cohort studies evaluating the association of coffee consumption with the risk of prostate cancer. The studies, taking place in North America (n=7), Europe (n=7), and Japan (n=2), included 1,081,586 men, of whom 57,732 went on to develop prostate cancer. To measure coffee consumption, 11 studies used food-frequency questionnaires and five self-administered dietary questionnaires. Most studies adjusted for potential confounders, such as age, family history, race, cigarette smoking, alcohol consumption, and physical activity.Results of the pooled analysis showed that in comparison with the lowest category of coffee consumption, the highest category was associated with a reduction in prostate cancer of 9% (RR 0.91, 95%CI 0.84 to 0.98, I2=53.2%). The investigators further found that each additional daily cup was associated with a reduction in risk of 1% (pooled RR 0.988, 95%CI 0.981 to 0.995).

Exploring the different types of diagnosis, the investigators found that for localised prostate cancer the reduction was 7% (RR 0.93, 95%CI 0.87 to 0.99); for advanced prostate cancer 12% (RR 0.88, 95%CI 0.71 to 1.09); and for fatal prostate cancer 16% (RR 0.84, 95%CI 0.66 to 1.08).

Plausible biological mechanisms for the findings, highlighted by the authors, include coffee improving glucose metabolism, decreasing concentrations of plasma insulin and insulin-like growth factor-1, having anti-inflammatory and antioxidant effects, and influencing levels of sex hormones. The influence on sex hormones may relate to caffeine content. A nested case-control study  found that caffeinated coffee intakes were associated with increased sex hormone-binding globulin (SHBG) levels, but that the effect was not observed for decaffeinated coffee.

The findings, write the authors, need to be interpreted with caution since the amount of coffee consumed may have been misclassified as it depended on subject recall, and the type of coffee and brewing methods used varied between studies. Additionally, due to the observational design of the included cohort studies, unmeasured or uncontrolled factors in the original studies may have skewed pooled risk estimates. “If the association is further proved to be a causal effect, men might be encouraged to increase their coffee consumption to potentially decrease the risk of prostate cancer,” conclude the authors.

Carlo La Vecchia, Professor of Medical Statistics and Epidemiology at Università degli Studi di Milano, Italy, told Cancer World, “This study is an additional contribution that allows us to exclude any positive associations between coffee consumption and excess prostate cancer deaths. However, given the possibility of observational study bias errors, the suggestion higher intakes of coffee protect against prostate remains open to discussion.” One example of reverse causation, he adds, is the possibility that men with prostate cancer limit their coffee intake due to its pro diuretic effects.

Photo credits: Thomas Noonan

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • caffeine
  • prostate cancer
Janet Fricker

Janet Fricker is a medical writer specialising in oncology and cardiology. After researching articles for Cancerworld she runs, swims, and eats porridge.

Previous Article
  • News

Financial burden on older adults with advanced cancer worsens quality of life

  • 15 January 2021
  • Janet Fricker
View Post
Next Article
  • Patient’s Voices
  • Voices

From the New Yorker: What Cancer Takes Away

  • 22 January 2021
  • Anne Boyer
View Post
You May Also Like
View Post
  • News

Key link identified in mechanism promoting lung metastases from breast cancer

  • Janet Fricker
  • 17 February 2025
View Post
  • News

OncoDaily Acquires CancerWorld: A New Era in Oncology Media

  • Christopher Greenberg
  • 22 January 2025
View Post
  • News

Second-generation BTK inhibitor shows promise as fixed-duration therapy in CLL

  • Janet Fricker
  • 18 December 2024
View Post
  • News

New evidence can help inform decisions on managing early-onset breast cancer linked to BRCA mutations

  • Janet Fricker
  • 18 December 2024
View Post
  • News

Gut microbiota influence effectiveness of tamoxifen in breast cancer

  • Janet Fricker
  • 6 December 2024
View Post
  • News

Radiotherapy prior to immunotherapy is the best treatment sequence for melanoma related brain metastases

  • Janet Fricker
  • 6 December 2024
View Post
  • News

Study helps solve the puzzle of checkpoint inhibitor myocarditis

  • Janet Fricker
  • 22 November 2024
View Post
  • News

Smoking cessation fundamental to first-line cancer care

  • Janet Fricker
  • 21 November 2024
search
or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • Key link identified in mechanism promoting lung metastases from breast cancer
    • 17 February 2025
  • OncoDaily Acquires CancerWorld: A New Era in Oncology Media
    • 22 January 2025
  • Second-generation BTK inhibitor shows promise as fixed-duration therapy in CLL
    • 18 December 2024
  • New evidence can help inform decisions on managing early-onset breast cancer linked to BRCA mutations
    • 18 December 2024
  • Gut microbiota influence effectiveness of tamoxifen in breast cancer
    • 6 December 2024
Article
  • China’s integrated cancer care guidelines ‘reflect self-confidence’ in the field of oncology
    • 15 February 2025
  • Europe’s cancer agenda: how we keep it a priority in changing times
    • 20 December 2024
  • Humour: an essential tool in cancer care and communication
    • 18 December 2024
Social

Would you follow us ?

Contents
  • Stella Kyriakides: using her voice to improve health in Europe
    • 22 November 2024
  • Bulgarian oncologist Assia Konsoulova
    Assia Konsoulova: improving Bulgaria’s cancer system one oasis at a time
    • 8 November 2024
  • Mohit Singh and his mother Amrita: they are the protagonists of a long and ultimately unsuccessful journey across India in search of cures for her cancer
    ‘I feel guilty sometimes’: a young carer reflects on three years of a losing battle to save his mum
    • 24 October 2024
MENU
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine
  • About us
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is published by OncoDaily (P53 Inc.) | Mailing Address: 867 Boylston st, 5th floor, Ste 1094 Boston, MA 02116, United States | [email protected]

Archivio Cancerworld

Input your search keywords and press Enter.